Tag - IND

Developments

CytoDyn files IND and Phase 2 protocol to treat NASH with leronlimab

CytoDyn (OTCQB:CYDY) filed an IND and a Phase 2 clinical trial protocol with the FDA for the treatment of non-alcoholic steatohepatitis (NASH) with its lead drug candidate, leronlimab. Based on published reports of the...

September 4, 2019

Feature

Harvard Apparatus to file IND for regenerated trachea trial

By Len Zehr Harvard Apparatus Regenerative Technology (NASDAQ:HART) plans to file an IND later this year for a pivotal trial of the world’s first regenerated trachea transplant in patients facing life-threatening...

January 13, 2015

Tag - IND

CytoDyn files IND and Phase 2 protocol to treat NASH with leronlimab

Harvard Apparatus to file IND for regenerated trachea trial

General

More